Tag: FDA

GW Pharma Epidiolex FDA Decision Date Set for June 27th

GW Pharmaceuticals Announces Acceptance of NDA Filing for Epidiolex(R) (cannabidiol) in the treatment of Lennox-Gastaut syndrome and Dravet syndrome LONDON and CARLSBAD, Calif., Dec. 28, 2017 (GLOBE NEWSWIRE) —...
- December 28th, 2017 at 7:25 am

FDA Warns Cannabis Companies About False Cancer Claims

FDA warns companies marketing unproven products, derived from marijuana, that claim to treat or cure cancer November 1, 2017 As part of the U.S. Food and Drug Administration’s ongoing...
- November 1st, 2017 at 12:42 pm

FDA Chills Cannabidiol Marketplace

Robert T. Hoban, Esq. Hoban & Feola, LLC (www.HobanandFeola.com) Guest Post – CBD:  Is There a Chill in the Air (Marketplace)?* Cannabidiol (CBD), which is one of many non-psychoactive substances...
- February 15th, 2016 at 3:00 pm

CV Sciences Responds to Cannabidiol FDA Warnings

Earlier today, the Food & Drug Administration (FDA) posted 8 warning letters issued to marketers of products containing cannabidiol (CBD).  Two of the companies receiving the letters were criticized for claims...
- February 10th, 2016 at 8:43 pm